Toggle light / dark theme

Breakthrough for pancreatic cancer labelled ‘closest thing to a cure’

Doctors today hailed a breakthrough in the fight against pancreatic cancer after a new drug combination was shown to shrink and even erase tumours in a clinical trial.

Daraxonrasib has been credited as one of the most significant advances against the deadly disease in decades.

Earlier this year, US health officials approved the daily pill after it was found to double survival in patients with aggressive forms of the disease, from 6.7 to 13.2 months.

Leave a Comment

Lifeboat Foundation respects your privacy! Your email address will not be published.